S&P 500
7,757.17
+44.60
+0.58%
Dow
52,856.09
+360.19
+0.69%
Nasdaq
26,702.86
+278.04
+1.05%
NYSE Composite
24,253.12
+62.52
+0.26%
Russell 2000
2,781.02
+7.60
+0.27%
VIX
16.68
-0.63
-3.64%
MBOT · Microbot Medical Inc.
NASDAQ NMS - GLOBAL MARKET - BOATS Real Time Price • USD
Microbot Medical Inc (MBOT)
NASDAQ NMS - GLOBAL MARKET
Health Care
$0.94
-0.01
(-0.75%)
● At close: October 21 at 4:00:00 PM EDT
$0.94
+0.00
(+0.02%)
Overnight:
11:16:18 PM EDT
DAY'S RANGE
$0.94
$0.94
$0.96
52-WEEK RANGE
$0.94
$0.93
$2.89
What's happening
- MBOT is down 0.75% today, trading at $0.94. — Live quote
- It's trading within 3% of its 52-week low ($0.93). (Finnhub fundamentals)
- Volume today (5,711) is well below its 3-month average of 694,850. (Finnhub fundamentals)
- Reports earnings on 2026-11-10, 19 days away. (Finnhub earnings calendar)
- Last quarter's EPS missed estimates: $-0.08 actual vs. $-0.08 estimated (-2.3%). (Finnhub earnings history)
Deterministic template sentences filled in from the same sourced figures shown elsewhere on this page -- not an AI-written summary, no live model call.
Key Statistics
Analyst Recommendations
Strong buy 2
Buy 6
Hold 1
Sell 0
Strong sell 0
Aggregate ratings for 2026-10-01 (9 analysts polled by Finnhub) — consensus count.
Performance Overview (Trailing returns vs S&P 500 benchmark)
YTD RETURN
MBOT
-52.62%
vs S&P 500
-65.40%
1-YEAR RETURN
MBOT
-66.16%
vs S&P 500
-80.72%
6-MONTH RETURN
MBOT
-60.36%
3-MONTH RETURN
MBOT
-47.36%
Earnings Trends (Quarterly EPS Actual vs Estimate)
2026-07-26 (Q2 2026)
$-0.08
Est. $-0.08
MISS -2.3%
2026-04-26 (Q1 2026)
$-0.05
Est. $-0.08
BEAT +36.1%
2026-01-26 (Q4 2025)
$-0.04
Est. $-0.06
BEAT +34.6%
2025-10-26 (Q3 2025)
$-0.07
Est. $-0.06
MISS -14.4%
Valuation Measures & Ratios
Enterprise Value4$61.5M
Forward P/E5—
PEG Ratio6—
Price / Sales (TTM1)186.78
Price / Book71.90
EV4 / Revenue177.67
EV4 / EBITDA2.41
Profit Margin-2687.28%
Operating Margin-3036.99%
Return on Equity (ROE8)-21.87%
Return on Assets (ROA9)-20.77%
Avg Volume (3M)694,850
Quarterly history (5 periods)
| Measure | Jun '26 | Mar '26 | Sep '25 | Jun '25 | Mar '25 |
|---|---|---|---|---|---|
| Market cap | $136.5M | $177.7M | $156.4M | $88.4M | $48.8M |
| P/E | -8.33 | -13.31 | -12.13 | -7.50 | -4.58 |
| Price/Book | 1.98 | 2.40 | 2.00 | 2.91 | 1.68 |
| EV/EBITDA | -7.39 | -11.70 | -10.81 | — | — |
| ROE | -23.76% | -18.01% | -16.48% | -38.81% | -36.79% |
| ROA | -22.32% | -17.10% | -15.77% | -35.56% | -34.48% |
Trailing-twelve-month ratios computed from SEC EDGAR quarterly figures and historical daily close prices (Alpaca). Diluted shares are derived from Net income ÷ EPS (diluted) for each quarter, not separately reported. Forward P/E/PEG unavailable (no free data source).
Glossary — what these abbreviations mean
- 1. TTM
- Trailing twelve months — the sum of the last four reported quarters, not a calendar year or the single latest quarter.
- 2. EPS
- Earnings per share — net income divided by diluted shares outstanding.
- 3. Beta
- A stock's historical volatility relative to the overall market. Above 1 means it has moved more than the market; below 1, less.
- 4. EV (Enterprise Value)
- Market cap plus total debt minus cash — roughly what it would cost to buy the whole company, debt included.
- 5. Forward P/E
- Price divided by analysts' estimated earnings for the next 12 months, instead of trailing actual earnings.
- 6. PEG Ratio
- P/E divided by expected earnings growth rate. A lower number can indicate a stock is cheap relative to how fast it's expected to grow.
- 7. Price / Book
- Share price divided by book value (assets minus liabilities) per share.
- 8. ROE
- Return on equity — net income divided by shareholders' equity, a measure of how efficiently a company turns equity into profit.
- 9. ROA
- Return on assets — net income divided by total assets, a measure of how efficiently a company turns assets into profit.
- 10. MRQ
- Most recent quarter — the single latest reported period, as opposed to TTM. The Financials section's "Quarterly" view below shows MRQ-style figures.
- 11. YoY
- Year over year — percent change versus the same period one year earlier, used for growth figures like those on Compare cards and the Screener.
Short Interest
Shares Short6,638,458
Change from Prior Settlement-6.14%
% of Float—
Days to Cover (Short Ratio)12.04
Source: FINRA Rule 4560 consolidated short interest, settlement date 2026-09-30. Reported bi-monthly with a reporting lag — not real-time.
Quotes and the 1-day extended-hours chart: Yahoo Finance. Longer historical charts: Alpaca (IEX feed) — real-time but IEX-only volume (~2.5% of consolidated market volume). Fundamentals + earnings: Finnhub.
Price history
Events
Drag horizontally to zoom into a section; use Reset view to restore all observations.
Technical signal summary
Calculating from the latest year of daily price history…
Show Technical Analysis Breakdown ▾ 10 Indicators
Not investment advice — read several signals together.
Indicators None active
Loading chart…
History limited by data provider; markers are heuristics, not signals.
Peer and sector context
No reviewed peer group is available for this symbol.
Balanced evidence
A deterministic summary of sourced facts—not an AI verdict.
Potential strengths
- Latest SEC filing is Form 8-K, filed 2026-10-20; review it for current changes and risks. SEC EDGAR ↗
Potential concerns
- Revenue growth is -50.0% on the provider's reported measure. Finnhub fundamentals ↗
- Net profit margin is -2687.3%. Finnhub fundamentals ↗
- Trailing 52-week price return is -66.2%. Finnhub market metrics ↗
Rule-based facts only; absence from either side is not evidence, and this is not a recommendation.
More on MBOT
No accessible free API for these — links go to the source directly.
Financials
Fundamental trends
Visualized from the same SEC figures in the tables below.
Income statement
| Line item | Jun '26 | Mar '26 | Sep '25 | Jun '25 | Mar '25 | Sep '24 | Jun '24 | Mar '24 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $241.0K | $105.0K | — | — | — | — | — | — |
| Gross profit | -$643.0K | $2.0K | — | — | — | — | — | — |
| Operating income | -$6.2M | -$4.3M | -$3.9M | -$3.7M | -$3.0M | -$3.3M | -$2.5M | -$2.4M |
| Net income | -$5.6M | -$3.7M | -$3.6M | -$3.5M | -$2.6M | -$3.2M | -$2.5M | -$2.4M |
| EPS (diluted) | $-0.08 | $-0.05 | $-0.07 | $-0.10 | $-0.08 | $-0.20 | $-0.17 | $-0.17 |
| EPS (basic) | $-0.08 | $-0.05 | $-0.07 | $-0.10 | $-0.08 | $-0.20 | $-0.17 | $-0.17 |
| Operating margin | -$2.6K | -$4.1K | — | — | — | — | — | — |
| Net margin | -$2.3K | -$3.5K | — | — | — | — | — | — |
Balance sheet
| Line item | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 |
|---|---|---|---|---|---|---|---|---|
| Total assets | $73.4M | $78.1M | $81.5M | $81.8M | $33.1M | $30.9M | $6.0M | $5.2M |
| Total liabilities | $4.4M | $4.0M | $4.0M | $3.5M | $2.8M | $1.9M | $2.5M | $1.4M |
| Stockholders' equity | $68.9M | $74.1M | $77.6M | $78.2M | $30.4M | $29.0M | $3.5M | $3.8M |
| Total current assets | $72.2M | $76.5M | $79.8M | $80.8M | $32.9M | $30.7M | $5.8M | $5.0M |
| Total current liabilities | $3.9M | $3.4M | $3.4M | $2.9M | $2.7M | $1.9M | $2.5M | $1.4M |
| Cash & equivalents | $3.2M | $3.7M | $3.9M | $6.7M | $4.1M | $3.2M | $3.1M | $479.0K |
| Marketable securities (current) | $64.2M | $68.8M | $74.7M | $73.5M | $28.6M | $27.2M | $2.4M | $3.9M |
| Accounts receivable | $176.0K | $105.0K | — | — | — | — | — | — |
| Inventory | $2.9M | $2.3M | $584.0K | — | — | — | — | — |
| Other current assets | — | — | — | — | — | — | — | — |
| Property, plant & equipment | $316.0K | $188.0K | $93.0K | $78.0K | $75.0K | $78.0K | $80.0K | $99.0K |
| Goodwill | — | — | — | — | — | — | — | — |
| Intangible assets | — | — | — | — | — | — | — | — |
| Other non-current assets | — | — | — | — | — | — | — | — |
| Accounts payable | $871.0K | $1.1M | $511.0K | $509.0K | $503.0K | $186.0K | $165.0K | $246.0K |
| Accrued liabilities | $2.7M | $2.0M | $2.6M | $2.1M | $2.1M | $1.6M | $2.2M | $1.1M |
| Deferred revenue (current) | — | — | — | — | — | — | — | — |
| Short-term debt | — | — | — | — | — | — | — | — |
| Other current liabilities | — | — | $5.0K | — | — | — | $5.0K | — |
| Long-term debt | — | — | — | — | — | — | — | — |
| Other non-current liabilities | — | — | — | — | — | — | — | — |
| Common stock & paid-in capital | $672.0K | $672.0K | $672.0K | $659.0K | $380.0K | $348.0K | $195.0K | $168.0K |
| Retained earnings | -$113.4M | -$107.8M | -$104.1M | -$100.6M | -$97.0M | -$93.5M | -$90.9M | -$87.6M |
| Accumulated other comprehensive income (loss) | — | — | — | — | — | — | — | — |
Cash flow
| Line item | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$5.0M | -$5.1M | -$3.8M | -$3.8M | -$2.6M | -$2.9M | -$1.7M | -$2.8M |
| Investing cash flow | $4.5M | $5.0M | -$1.5M | -$44.7M | -$1.3M | -$24.8M | $1.5M | $140.0K |
| Financing cash flow | $16.0K | — | $2.5M | $51.2M | $4.8M | $27.8M | $2.8M | $633.0K |
| Free cash flow | -$5.1M | -$5.2M | -$3.8M | -$3.9M | -$2.6M | -$2.9M | -$1.7M | -$2.8M |
| Capital expenditures | $142.0K | $108.0K | $25.0K | $13.0K | $9.0K | $13.0K | $7.0K | $0 |
| Depreciation & amortization | $15.0K | $12.0K | $10.0K | $10.0K | $12.0K | $15.0K | $26.0K | $23.0K |
| Share-based compensation | $433.0K | $222.0K | $236.0K | $565.0K | $237.0K | $256.0K | $282.0K | $283.0K |
| Change in accounts receivable | $71.0K | $105.0K | — | — | — | — | — | — |
| Change in inventory | $650.0K | $1.7M | $584.0K | — | — | — | — | — |
| Purchases of investments | $629.0K | $441.0K | — | — | $3.8M | $28.1M | — | — |
| Other investing activities | — | — | — | — | — | — | — | — |
| Debt issued | — | — | — | — | — | — | — | — |
| Debt repaid | — | — | — | — | — | — | — | — |
Income statement
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Gross profit | — | — | — | — | — |
| Operating income | -$14.7M | -$11.6M | -$9.9M | -$13.3M | -$11.4M |
| Net income | -$13.1M | -$11.4M | -$10.7M | -$13.2M | -$11.3M |
| EPS (diluted) | $-0.29 | $-0.73 | $-1.05 | $-1.81 | — |
| EPS (basic) | $-0.29 | $-0.73 | $-1.05 | $-1.81 | $-1.59 |
Balance sheet
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Total assets | $81.5M | $6.0M | $8.3M | $9.5M | $16.8M |
| Total liabilities | $4.0M | $2.5M | $3.8M | $2.2M | $2.4M |
| Stockholders' equity | $77.6M | $3.5M | $4.5M | $7.3M | $14.4M |
| Total current assets | $79.8M | $5.8M | $7.9M | $8.8M | $15.9M |
| Total current liabilities | $3.4M | $2.5M | $3.8M | $2.1M | $2.0M |
| Cash & equivalents | $3.9M | $3.1M | $2.5M | $2.4M | $13.5M |
| Marketable securities (current) | $74.7M | $2.4M | $3.9M | $5.8M | $2.0M |
| Accounts receivable | — | — | — | — | — |
| Inventory | $584.0K | — | — | — | — |
| Other current assets | — | — | $1.3M | — | $300.0K |
| Property, plant & equipment | $93.0K | $80.0K | $146.0K | $221.0K | $244.0K |
| Goodwill | — | — | — | — | — |
| Intangible assets | — | — | — | — | — |
| Other non-current assets | — | — | — | — | — |
| Accounts payable | $511.0K | $165.0K | — | $116.0K | $279.0K |
| Accrued liabilities | $2.6M | $2.2M | $1.0M | $1.7M | $1.4M |
| Deferred revenue (current) | — | — | — | — | — |
| Short-term debt | — | — | — | — | — |
| Other current liabilities | $5.0K | $5.0K | $79.0K | — | — |
| Long-term debt | — | — | — | — | — |
| Other non-current liabilities | — | — | — | — | — |
| Common stock & paid-in capital | $672.0K | $195.0K | $118.0K | $80.0K | $72.0K |
| Retained earnings | -$104.1M | -$90.9M | -$79.5M | -$68.8M | -$55.6M |
| Accumulated other comprehensive income (loss) | — | — | — | — | — |
Cash flow
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Operating cash flow | -$13.0M | -$8.8M | -$8.5M | -$11.5M | -$9.4M |
| Investing cash flow | -$72.4M | $1.5M | $2.0M | -$3.8M | $3.2M |
| Financing cash flow | $86.2M | $7.9M | $6.6M | $4.3M | — |
| Free cash flow | -$13.1M | -$8.9M | -$8.6M | -$11.6M | -$9.4M |
| Capital expenditures | $60.0K | $25.0K | $33.0K | $84.0K | $69.0K |
| Depreciation & amortization | $47.0K | $91.0K | $106.0K | $102.0K | $76.0K |
| Share-based compensation | $1.1M | $1.3M | $1.4M | $1.8M | $1.4M |
| Change in accounts receivable | — | — | — | — | — |
| Change in inventory | $584.0K | — | — | — | — |
| Purchases of investments | — | — | $10.1M | $3.7M | — |
| Other investing activities | — | — | -$3.0K | $3.0K | — |
| Debt issued | — | — | — | — | — |
| Debt repaid | — | — | — | — | — |
Source: SEC EDGAR XBRL filings (10-Q/10-K), as originally tagged by the company. Quarterly cash flow is reconstructed by de-cumulating fiscal-year-to-date figures (how cash flow is tagged in 10-Qs); other quarterly lines are reported directly.
Institutional holders
SEC Form 13F filers holding MBOT as of the latest reported quarter. 13F only covers investment managers with $100M+ in assets — this is not a complete ownership picture, and does not include insiders (see Recent SEC filings below) or non-13F-eligible holders.
Institutional ownership is not available for this symbol right now.
Insider activity
Directors, officers, and 10%+ owners' reported transactions from SEC Form 4. A filing reports a transaction; it does not by itself explain why it happened.
Insider activity is not available for this symbol right now.
Recent SEC filings
Official company reports and insider transaction filings. Form 4 reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR submissions · updated 2026-10-21 23:38 UTC
| Filed | Form | Report period | Official filing |
|---|---|---|---|
| 2026-10-20 | 8-K | 2026-10-14 | View on SEC.gov → |
| 2026-10-06 | 8-K | 2026-10-06 | View on SEC.gov → |
| 2026-09-28 | 8-K | 2026-09-25 | View on SEC.gov → |
| 2026-08-11 | 8-K | 2026-08-11 | View on SEC.gov → |
| 2026-08-11 | 10-Q | 2026-06-30 | View on SEC.gov → |
| 2026-08-07 | 8-K | 2026-08-06 | View on SEC.gov → |
| 2026-07-21 | 8-K | 2026-07-21 | View on SEC.gov → |
| 2026-07-07 | 8-K | 2026-07-07 | View on SEC.gov → |
| 2026-06-30 | 8-K | 2026-06-30 | View on SEC.gov → |
| 2026-06-25 | 8-K | 2026-06-25 | View on SEC.gov → |
| 2026-06-23 | 8-K | 2026-06-23 | View on SEC.gov → |
| 2026-06-16 | 8-K | 2026-06-16 | View on SEC.gov → |
Recent news
Headlines about MBOT (Microbot Medical Inc.). Links open the publisher — we don’t host full articles.
-
Microbot Medical stock price target maintained at $12 by H.C. Wainwright
Investing.com · 2026-10-21 -
HC Wainwright & Co. reiterates Buy rating on Microbot Medical, $12 price target
TradingView · 2026-10-21 -
Microbot Medical Inc. (MBOT) stock price, news, quote and history
Yahoo Finance UK · 2026-10-21 -
HC Wainwright & Co. Reiterates Buy on Microbot Medical, Maintains $12 Price Target
Benzinga · 2026-10-21 -
Microbot Medical Inc. (MBOT) Stock Price, News, Quote & History
Yahoo! Finance Canada · 2026-10-21 -
Microbot Medical® Granted Multiple New Patents, Further Strengthening Its Global Intellectual Property Portfolio
Yahoo · 2026-10-20 -
Microbot Medical Receives Several New Patent Approvals Across US, Japan, China And Canada, Further Strengthening Its Global IP Portfolio
Benzinga · 2026-10-20 -
Microbot Medical stock has a negative price-to-earnings ratio of -3.64
AD HOC NEWS · 2026-10-17
No headlines in this category right now — try “All”.